Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Isodose Control

2003 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a medical technology company. The company is engaged in the development of brachytherapy products for the treatment of cancer. It also offers radiation therapy for cancer patients.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Hospitals/Inpatient Services
Other Healthcare Technology Systems
Acquirer
Primary Office
  • PO Box 615
  • 3900 Veenendaal
  • Netherlands

Isodose Control Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Isodose Control‘s full profile, request access.

Request full access to PitchBook

Isodose Control Executive Team (1)

Name Title Board
Seat
Contact
Info
Reinier vant Hooft Chief Executive Officer & Co-Founder